The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

Open Access

A mutant telomerase defective in nuclear‐cytoplasmic shuttling fails to immortalize cells and is associated with mitochondrial dysfunction

Olga A. Kovalenko

Department of Pharmacology and Physiology

Department of Pathology

Search for more papers by this author
Matthieu J. Caron

Department of Pharmacology and Physiology

Search for more papers by this author
Perihan Ulema

Department of Pharmacology and Physiology

Search for more papers by this author
Carolina Medrano

Department of Pharmacology and Physiology

Search for more papers by this author
Andrew P. Thomas

Department of Pharmacology and Physiology

Search for more papers by this author
Marcelo G. Bonini

Laboratory of Pharmacology, National Institute of Environmental and Health Sciences, 111 TW Alexander dr, MD F0‐02, Durham, NC 27709, USA

Present address: Section of Cardiology/Department of Pharmacology, University of Illinois at Chicago. 909 South Wolcott Ave, COMRB 3020, Chicago, IL 60612, USASearch for more papers by this author
Utz Herbig

Department of Microbiology and Molecular Genetics and New Jersey Medical School‐University Hospital Cancer Center, 205 South Orange Avenue, Cancer Center G1226, Newark, NJ 07101, USA

Search for more papers by this author
Janine H. Santos

Department of Pharmacology and Physiology

Search for more papers by this author
First published: 16 March 2010
Cited by: 41
Janine Hertzog Santos, Department of Pharmacology and Physiology, New Jersey Medical School of UMDNJ, Medical Sciences Building, H653, 185 South Orange Avenue, Newark, NJ 07103, USA. Tel.: +973 972 9729; fax: +973 972 7950; e‐mail:santosja@umdnj.edu

Summary

Telomerase is a reverse transcriptase specialized in telomere synthesis. The enzyme is primarily nuclear where it elongates telomeres, but many reports show that the catalytic component of telomerase (in humans called hTERT) also localizes outside of the nucleus, including in mitochondria. Shuttling of hTERT between nucleus and cytoplasm and vice versa has been reported, and different proteins shown to regulate such translocation. Exactly why telomerase moves between subcellular compartments is still unclear. In this study we report that mutations that disrupt the nuclear export signal (NES) of hTERT render it nuclear but unable to immortalize cells despite retention of catalytic activity in vitro. Overexpression of the mutant protein in primary fibroblasts is associated with telomere‐based cellular senescence, multinucleated cells and the activation of the DNA damage response genes ATM, Chk2 and p53. Mitochondria function is also impaired in the cells. We find that cells expressing the mutant hTERT produce high levels of mitochondrial reactive oxygen species and have damage in telomeric and extratelomeric DNA. Dysfunctional mitochondria are also observed in an ALT (alternative lengthening of telomeres) cell line that is insensitive to growth arrest induced by the mutant hTERT showing that mitochondrial impairment is not a consequence of the growth arrest. Our data indicate that mutations involving the NES of hTERT are associated with defects in telomere maintenance, mitochondrial function and cellular growth, and suggest targeting this region of hTERT as a potential new strategy for cancer treatment.

Introduction

Telomerase adds DNA repeats to the ends of linear chromosomes thereby preventing telomere shortening. The enzyme contains two minimal components: an RNA subunit (TR) that provides the template for telomeric DNA synthesis, and a reverse transcriptase protein (TERT) that mediates catalysis. TERT can also assemble with the RNA of the mitochondrial endoribonuclease giving rise to a competent RNA‐dependent RNA polymerase involved in gene expression regulation (Maida et al., 2009). Telomerase is expressed in germ cells and undifferentiated somatic cells, and in over 90% of human cancers (Shay & Wright, 2005). Early studies detected hTERT mRNA in telomerase‐negative cells (Kilian et al., 1997; Ramakrishnan et al., 1998). Recent evidence suggests that the protein is transiently expressed in every adult somatic cell, at least in S‐phase (Masutomi et al., 2003).

Many reports have shown that hTERT is found not only in the nucleus but also in the cytoplasm and including in mitochondria (Armbruster et al., 2001; Haendeler et al., 2003, 2004, 2009; Santos et al., 2004, 2006a; Ahmed et al., 2008). The extranuclear functions of telomerase are poorly understood. It has also been reported that hTERT shuttles between subcellular compartments. For instance, in resting CD4+ lymphocytes hTERT is primarily cytoplasmic but upon activation it translocates to the nucleus, a process controlled by the kinase Akt (Liu et al., 2001; Kimura et al., 2004). Under hydrogen peroxide (H2O2) and hyperoxia conditions, hTERT moves out of the nucleus into mitochondria in immortalized human fibroblasts (Ahmed et al., 2008); Scr kinase is responsible for the nuclear export of hTERT upon oxidative stress (Haendeler et al., 2003). 14‐3‐3 is also implicated in the nuclear‐cytoplasmic shuttling of hTERT by regulating its interaction with the nuclear exportin CRM1 (Seimiya et al., 2000). Other proteins reported to play a role in the intracellular localization of hTERT are PKC, NFkB and the phosphatases PP2A and Shp‐2 (Li et al., 1997; Akiyama et al., 2003; Kimura et al., 2004; Jakob et al., 2008; Ram et al., 2009).

Although it is well established that hTERT translocates between subcellular compartments, it is presently unclear why and exactly when this movement occurs. Cytoplasmic (or nonnuclear) hTERT is presumably nonfunctional and such localization suggested serving a regulatory role by limiting the amount of functional nuclear telomerase (Liu et al., 2001). The recent data about the mitochondrial localization of ectopically expressed and endogenous hTERT dispute this notion (Santos et al., 2004, 2006a; Ahmed et al., 2008; Haendeler et al., 2009; Caron et al., submitted). In this study, we found that residues involved in the shuttling of hTERT between nucleus and cytoplasm are required for the telomere elongation function of hTERT. Site‐directed mutagenesis of the nuclear export signal (NES) of hTERT resulted in a mutant protein that is unable to leave the nucleus. While the mutant retains catalytic activity in vitro, it is defective in cellular immortalization in vivo reminiscent of the DAT (dissociates activities of telomerase) phenotype described previously (Armbruster et al., 2001; Banik et al., 2002). Unlike DAT mutants that did not growth arrest prematurely, expression of the NES mutant rapidly caused cellular senescence. Mutant‐expressing cells also displayed dysfunctional mitochondria, elevated levels of reactive oxygen species (ROS), telomeric‐ and nontelomeric DNA double‐strand breaks, and activated DNA damage response (DDR) genes such as ATM, Chk2 and p53. Our findings suggest that the NES region of hTERT is involved with cellular immortalization and underscore the importance of this region for telomerase’s telomeric function and mitochondrial quality control.

Results

Disruption of the NES of hTERT abolishes its ability to translocate out of the nucleus

Nuclear export of hTERT is mediated by 14‐3‐3 and the nuclear exportin CRM1 (Seimiya et al., 2000). In trying to create a mutant that does not translocate into mitochondria, we disrupted the NES of hTERT by site‐directed mutagenesis. A putative NES had been previously identified on hTERT but the exact amino acid residues required for nuclear export of the protein were not identified (Seimiya et al., 2000). The software package NetNES1.1 predicted that leucine (L) substitutions at positions 980 and 987 would suffice to disrupt the NES of hTERT. We replaced these residues with alanine (L980A/L987AhTERT) and established the subcellular localization of the mutant protein using confocal microscopy, and Western blots in subcellular fractionations.

Mutant and wild‐type (WT) proteins were fused to enhanced green fluorescent protein (EGFP) and transiently transfected into HeLa cells. L980A/L987AhTERT‐EGFP was, as expected, nuclear and pretreatment for 2 h with 20 nm of leptomycin B, a potent inhibitor of the nuclear export machinery, did not impact its subcellular localization (Fig. 1A lower panels). Conversely and in agreement with previous work (Santos et al., 2004, 2006a; Ahmed et al., 2008), WT hTERT was both nuclear and cytoplasmic, including mitochondrial, but upon incubation with leptomycin B it lost its cytoplasmic localization in most cells (Fig. 1A upper panels). About 80% of cells expressing the WT protein showed hTERT in both nucleus and cytoplasm (including mitochondria) whereas in the mutant‐expressing cells 90% of hTERT was nuclear. Subcellular fractionations in cells stably expressing the proteins showed that the amount of hTERT in the mitochondria of the mutant was negligible (25‐fold lower than in cells expressing the WT protein; Fig. 1B). Herein, this mutant is referred to as NES‐hTERT.

Nuclear export signal (NES)‐hTERT is nuclear. Top shows amino acid sequences of WT and mutant hTERT; in bold and underlined are the residues that were substituted. (A) HeLa cells were transiently transfected with WT‐ or NES‐hTERT‐EGFP and analyzed under a confocal microscope 24 h after transfections. Cells were pre‐incubated for 2 h with 20 nm of leptomycin B to monitor changes in the intracellular localization of hTERT. Mitochondria were labeled with Mitotracker and are shown in red. Green represents the fusion proteins. (B) Cells were lysed and subcellular fractionations carried out maintaining nucleus (50 μg) and mitochondria (200 μg). Whole cell lysates (50 μg) were used as positive controls; actin and ND1 were used as loading controls. The latter is a mtDNA‐encoded protein and was used to normalize the mitochondrial data. Details on the protocol for fractionations can be found in the Experimental Procedures. Graph shows data normalized to loading controls and adjusted to reflect the same amount of protein (50 μg) in all samples.

Expression of NES‐hTERT causes premature senescence in normal diploid fibroblasts

Having confirmed that NES‐hTERT was nuclear, we stably expressed it in primary human foreskin fibroblasts (NHF) that are telomerase‐negative, using retroviral transduction. We selected these cells because we had previously characterized WT hTERT in this cellular background (Santos et al., 2004, 2006a). Unexpectedly, we found that NHF‐expressing NES‐hTERT arrested growth prematurely, that is earlier than non‐hTERT parental irrespective of the vector in which it was expressed; doubling time of the cells increased significantly (Fig. 2A left panel). The same was observed when the mutant was expressed in another background strain GM7532 (from Coriell Repository; Fig. 2A right panel). Growth arrest was accompanied by flattened and enlarged morphology reminiscent of senescent cells (Fig. 2B). DNA profiles using propidium iodide (PI) and flow cytometry indicated that the cells were arrested in the G1/S transition (Fig. 2C left panel), which is typical of the growth arrest associated with senescence (Campisi & d’Adda di Fagagna, 2007). Analysis of the senescence markers senescence‐associated β galactosidase activity (SA β‐gal, Fig. 2B), p21WAF−1 (or p21) and p16INK4a (referred herein as p16, Fig. 2D) confirmed that NHF‐expressing NES‐hTERT were senescent. Single‐cell analysis showed that virtually all cells were positive for p21, and counterstaining of the same cells for p16 revealed that most but not all cells that were positive for p21 also upregulated p16 (example depicted in Fig. 2D). p21 upregulation was confirmed by immunoblots (Fig. 2E). We also detected polynuclei in cells expressing the mutant protein (about 5–10% of the cells, Fig. 2F). In all cases, cells shared the same enlarged cytoplasm. Multinucleated cells were not observed in non‐hTERT or WT‐expressing controls (data not shown).

Nuclear export signal (NES)‐hTERT cells are arrested at the G1/S transition and have features of cellular senescence. (A) Cells were infected with NES‐hTERT viruses and after 10 days of antibiotic selection the same number of cells per cell type (50 000) were seeded. Cell number was followed for 6 weeks. Parental non‐hTERT cells were used as controls. (B) Senescence‐associated β‐galactosidase was scored using the Cell Signaling Kit. Dark blue cells indicated with an arrow represent senescent cells. (C) Cell cycle analysis was performed by flow cytometry using propidium iodide (PI). Cells were synchronized by serum starvation overnight. Serum was added back to the medium and cells analyzed 8 h later. Data represent percentage of cells in each phase of the cell cycle determined with CellQuest and ModFit. Results are representative of three independent experiments. (D) p21 and p16 were evaluated at a single‐cell level by immunofluorescence using specific antibodies (see Experimental Procedures); 100 cells were analyzed per cell type. Nuclei were stained with DAPI and cells costained with p21 (green) or p16 (red). (E) Western blot of whole cell extracts (40 μg per lane) confirmed the upregulation of p21; tubulin was used as loading control. (F) Normal human fibroblasts (NHF) expressing NES‐hTERT was stained with DAPI, p21 and p16. Images show examples of cells with multiple nuclei. (G) GM847 fibroblasts expressing empty vector, WT or NES‐hTERT were synchronized by serum starvation and submitted to cell cycle analysis by fluorescence activated cell sorting (FACS) as in (A). Data are representative of two independent experiments.

Upregulation of p21 suggested the involvement of p53, a protein that participates in the growth arrest of senescent cells (Campisi & d’Adda di Fagagna, 2007). We therefore tested whether p53 indeed played a role in the cell cycle blockade triggered by expression of NES‐hTERT by expressing empty vector, WT and mutant hTERT in GM847, an SV40‐immortalized cell line in which both the p53/p21 and the p16/Rb senescence pathways are disrupted. In these cells, no cell cycle blockade was observed (Fig. 2G), suggesting a role for p53 in arresting NES‐hTERT‐expressing cells. GM847 cells carrying NES‐hTERT were maintained for continuous growth for two months, and no changes in phenotype or in the rate of cell division were observed (data not shown).

These results were intriguing given that NES‐hTERT was localized to the ‘correct’ subcellular compartment. Under our culture conditions, NHF undergo replicative senescence at about population doubling (PD) 50–60; most cells were infected at around PD24. The senescent phenotype observed in NES‐hTERT‐expressing cells was usually observed earlier than PD40 and irrespective of the PD in which the cells were infected. In some independent infections, NES‐hTERT‐expressing cells senesced as early as at PD28 (see example on Fig. 2A left panel). The same premature growth arrest was observed in a different strain (GM7532) although in this cellular background the growth defect was consistently observed later (see example on Fig. 2A right panel). GM7532 senesce between PDs 60 and 70 in our culture conditions (data not shown). As no additional exogenous stress was imposed upon the cells, these observations suggest that the translocation of hTERT between subcellular compartments is required for cellular immortalization.

It is possible that mutations in NES‐hTERT disrupted the protein expression levels or catalytic activity, ultimately leading to telomerase enzymatic activity below the threshold required for cellular immortalization. To test this, we analyzed the levels of hTERT mRNA and telomerase enzymatic activity in whole cellular extracts using, respectively, RT‐PCR and the telomeric repeat amplification protocol (TRAP). As shown in Fig. 3A, not only the RNA of the mutant protein was expressed at the same levels as WT hTERT but also NES‐hTERT was catalytically active as judged by the TRAP.

Nuclear export signal (NES)‐hTERT is expressed at same levels as WT and catalytically active in vitro but is biologically inactive in vivo. (A) Left panel: RT‐PCR for a fragment of hTERT and GAPDH; lane 1: WT hTERT, lane 2: NES‐hTERT. Right panel: telomeric repeat amplification protocol (TRAP) to detect telomerase enzymatic activity. Lane 1: WT hTERT, lane 2: NES‐hTERT, lane 3: positive control (HeLa cells) and lane 4 negative control. IC represents the internal control of the assay. Samples were RNase‐treated to ensure the signals resulted from telomerase enzymatic activity (not shown). (B) Normal human fibroblasts (NHF) and the hTERT derivatives were harvested at population doubling (PD) 23; data represent mean telomere restriction fragment (mTRF) measured by Southern blots. Samples were evaluated in duplicates.

Various manipulations on hTERT were shown to lead to biological inactivity (i.e, inability to extend telomeres in vivo) despite enzymatic activity in vitro (Counter et al., 1998; Armbruster et al., 2001; Banik et al., 2002). Thus, it is possible that NES‐hTERT while active as gauged by the TRAP is biologically inactive. To test this hypothesis, we measured mean telomeric length by Southern blotting based on the mean telomere restriction fragment technique (mTRF). Cells were freshly derived at PD15 and allowed to undergo 8 PDs prior to telomere measurements; at PD23, DNA was isolated from parental and the hTERT derivatives. Results are representative of duplicate experiments. Mean telomeric length in parental cells was 6.38 kb (Fig. 3B lane 1) and significantly longer in cells carrying the WT protein (8.66 kb; Fig. 3B lane 2), demonstrating that WT telomerase can efficiently extend telomeres. However, the mean telomeric length in cells carrying the mutant NES‐hTERT (6.21 kb) was comparable to that of the parental strain (Fig. 3B lane 3), indicating that the mutant is unable to extend telomeres in vivo. These data also show that the expression of NES‐hTERT per se does not cause telomere shortening.

It had been shown previously that high levels of telomerase activity in apparently nonstressed cells induce premature cellular senescence (Gorbunova et al., 2003). However, in our experiments, enzymatic activity of WT hTERT, which promoted cell growth, and NES‐hTERT, which promoted senescence, were very similar (Fig. 3A). In addition, protein levels of hTERT in the nucleus of the mutant cells were lower than in the WT (Fig. 1B), making it unlikely that the observed growth inhibitory effects of NES‐hTERT were attributable to the elevated levels of telomerase. In addition, average telomere length in NES‐hTERT was comparable to the nonimmortalized control (Fig. 3B) in contrast to the results of Gorbunova et al. (2003) who reported that their hTERT‐positive senescent cells had long telomeres.

Nuclear DNA damage and activation of the DDR are observed only in cells expressing NES‐hTERT

Mean telomere length was comparable between parental and NES‐hTERT‐expressing cells as shown in Fig. 3B. Despite this, the mutant cells consistently stopped cycling before the non‐hTERT counterparts, showing that the rapid rate of senescence in NHF NES‐hTERT was not because of the replication‐based telomere shortening. These observations led to the hypothesis that the telomeres of NES‐hTERT cells were damaged.

Dysfunctional telomeres, whether caused by gradual telomere erosion because of continuous cell proliferation or by stochastic telomeric DNA damage, induce a DNA double‐strand break (DSB)‐like response with activation of DNA repair proteins such as meiotic recombination 11 (MRE11), Nijmegen breakage syndrome 1 (Nbs1), 53‐binding protein 1 (53BP1), and phosphorylated forms of the ataxia telangiectasia mutated (ATM S1981), checkpoint protein 2 (Chk2 at T68) and histone H2AX (S139). These DNA damage factors form discrete foci at dysfunctional telomeres, which can be visualized by immunofluorescence (IF) (d’Adda di Fagagna et al., 2003). Telomere dysfunction‐induced foci (TIF) are distinguishable from DNA damage foci that form at nontelomeric sites because of the presence of telomeric sequences along with the DNA damage factors (Takai et al., 2003).

To test whether the telomeres of NES‐hTERT cells were damaged, we probed activation of proteins involved in the DSB‐like response or DDR and quantified TIF in single cells using microscopy. We also evaluated genomic DNA damage as a surrogate of overall chromosome integrity using gene‐specific quantitative PCR (QPCR, Santos et al., 2002, 2006b; Kovalenko & Santos, 2009). The DDR proteins studied included serine 139 phosphorylated H2AX (γH2AX), activated ATM (ATM‐S1981) and Chk2 (N‐T68), as well as phosphorylation of serine 15 (S15) on p53. Controls included NHF (hTERT‐negative) at PD26 and NHF‐expressing WT hTERT.

While very few control or WT hTERT‐expressing cells displayed visible γH2AX foci (fewer than 12%), almost all NES‐hTERT‐expressing cells displayed at least one visible γH2AX focus (Fig. 4A; quantification on the graph on panel B). γH2AX colocalized with active ATM and Chk2 kinases, and all γH2AX‐positive cells displayed elevated levels of p53S15 (Fig. 4A), demonstrating activation of the G1 DNA double‐strand break checkpoint (Campisi & d’Adda di Fagagna, 2007). None of these markers were detected at significant levels in the non‐hTERT or WT‐expressing control cultures (Fig. 4B and data not shown).

Nuclear DNA damage at telomeres and at nontelomeric sites is present in nuclear export signal (NES)‐hTERT‐expressing cells. (A) Cells were immunostained with antibodies against γH2AX (left panels, green) and phospho‐ATM(S1981), phospho‐Chk2(T68), and phospho‐p53(S15) (center panels, red). DNA was counterstained with DAPI (blue). Merged images are shown in the right panels. Data are representative of results obtained with normal human fibroblasts (NHF) NES‐hTERT. (B) Percentage of cells positive for γH2AX foci. The number of foci per cell is represented as the different colors in each bar graph according to the accompanying legend. (C) Cells were processed by immunoFISH to simultaneously visualize γH2AX (green) and telomeres (red). DNA was counterstained with DAPI (blue). Enlarged versions of numbered γH2AX foci are depicted in the bottom panels. Data represent results obtained for NHF NES‐hTERT. Scale bar: 20 μm. (D) Graph shows percentage of total DNA damage foci that localized at telomeres (TIF) based on single‐cell counts as represented in (C). (E) Overall nuclear DNA damage was estimated using QPCR (Santos et al., 2002, 2006b; Kovalenko & Santos, 2009). Total genomic DNA was isolated, and DNA integrity analyzed using primers that amplify a 13.5‐ Kb fragment of the β‐globin gene. Statistical analysis was evaluated using Student’s t‐test; *corresponds to P ≤ 0.05. Error bars represent ± SEM; average of three independent analyses from independently derived cell lines is shown.

Next, we determined whether DNA damage foci colocalized with telomeres, as performed by us previously (Herbig et al., 2004). A cell was scored TIF positive when 50% or greater of its DNA damage foci colocalized with telomeric DNA sequences (see representative image on Fig. 4C). Consistent with our previous observations (Herbig et al., 2004), about only 10% of early passage NHF was TIF positive (Fig. 4D). Expression of WT hTERT reduced the levels of TIF‐positive cells to < 10%, demonstrating that telomerase efficiently prevents telomere dysfunction in these cells. In contrast, over 60% of NES‐hTERT‐expressing cells were TIF positive (Fig. 4C and D). Together, the results presented in Fig. 4A‐D show that telomeres in NES‐hTERT cells trigger a DSB‐like response.

Finally, we estimated the basal levels of nuclear DNA lesions using QPCR as a surrogate of genomic DNA integrity. QPCR has been used extensively by us and others to identify damage in both nuclear and mitochondrial genomes, and has proven particularly useful in the identification of oxidative stress‐mediated damage (Sobol et al., 2002; Santos et al., 2003; Sawyer et al., 2003; Shukla et al., 2003, Sorolla et al., 2008). The QPCR assay measures integrity of DNA using long PCR targets. The results obtained after PCR amplifications of the target DNA are used to estimate the lesion frequency present on each DNA strand based on a Poisson distribution. Presence of lesions reflect that the sample of interest amplifies less than its control while negative number of lesions can be observed when the DNA of a given sample amplifies better than its respective control (for more details on the assay see Santos et al., 2002, 2006b; Kovalenko & Santos, 2009). The nuclear fragment amplified in this analysis was 13.5 kb in length. Assuming that damage is randomly distributed, QPCR allows an overall picture of the integrity of the genome under study. Sensitivity limit of the technique is 1 lesion in every 100 000 bases (Santos et al., 2002, 2006b; Kovalenko & Santos, 2009).

We analyzed nuclear DNA (nDNA) integrity in parental cells and in the WT or mutant derivatives. Experiments were reproduced using independently derived cultures in PDs where no signs of cellular senescence were apparent in either parental or NES‐hTERT cells. As presented in Fig. 4E, cells expressing NES‐hTERT had significantly higher levels of nDNA damage than that in the non‐hTERT and the WT‐expressing counterparts, suggesting that telomeres in NES‐hTERT‐expressing cells likely have DNA lesions.

Impaired mitochondria are found in NES‐hTERT‐expressing cells

The next obvious question that arose was how could a mutant hTERT that is impaired in subcellular shuttling be involved with nDNA damage in telomeric and nontelomeric sites? We and others have shown that hTERT is present not only in the nucleus but also in mitochondria (Santos et al., 2004, 2006a; Ahmed et al., 2008; Haendeler et al., 2009) and our data revealed almost complete absence of hTERT in mitochondria of the mutant‐expressing cells (Fig. 1). Mitochondria are the main source of endogenous ROS and it has been shown that cells expressing WT hTERT have improved mitochondrial function under normal conditions, including decreased ROS generation (Ahmed et al., 2008; Haendeler et al., 2009). Thus, another potential effect of impaired hTERT shuttling is improper mitochondrial ‘regulation’ and mitochondrial dysfunction.

The mitochondrial genome is a critical target for oxidative damage primarily because of its proximity to the site of ROS generation. Once damaged, mtDNA amplify oxidative stress because of the decreased expression of critical protein components of the electron transport chain. Such effects lead to a vicious cycle of increasing ROS generation and organellar deregulation that can eventually trigger apoptosis (Van Houten et al., 2006; Wallace, 2008). Thus, mtDNA integrity is a good indicator of endogenous oxidative stress and proper mitochondrial function. To test whether mitochondria were impaired in NES‐hTERT cells, we evaluated different markers of mitochondrial function such as integrity of the mtDNA and basal rates of ROS production. We concomitantly monitored levels of oxygen consumption because it can influence the rate of ROS formation (Murphy, 2009). Finally, we also evaluated the mitochondrial ultrastructure by electron microscopy (EM).

We estimated the basal levels of mtDNA damage using QPCR. One of the advantages of using QPCR to estimate DNA damage is that both nuclear and mitochondrial genomes can be evaluated in the same sample (Kovalenko & Santos, 2009). We thus took the samples used in Fig. 4E, including cell lines derived at independent times in the both NHF and GM7532 backgrounds, to evaluate the integrity of the mtDNA from parental, WT and NES‐hTERT cells. We added to this analysis samples from freshly derived cells in which we included a senescent control. Senescent cells were shown to carry dysfunctional mitochondria (Passos et al., 2007). At the time of these analyses neither parental nor NES‐hTERT had signs of cellular senescence (that is, they were still cycling).

As presented in Fig. 5A, mtDNA damage was significantly higher in NES‐hTERT‐expressing cells when compared to young non‐hTERT and to WT hTERT controls. Levels of mtDNA damage paralleled that of nDNA damage (Fig. 4E). Lesions on NES‐hTERT cells while high were still statistically lower than their senescent counterparts (Fig. 5A, compare bars on the extreme right; P = 0.05).

Mitochondrial DNA damage, increased ROS generation and rate of proton leak are detected prior to senescence in normal human fibroblasts (NHF) nuclear export signal (NES)‐hTERT‐expressing cells. (A) Total genomic DNA was isolated, and mtDNA integrity analyzed using primers that amplify a 8.9‐ Kb fragment of the mitochondrial genome. Data were normalized to mtDNA content based on amplification of a small 230‐ bp fragment as described previously (Santos et al., 2002, 2006b; Kovalenko & Santos, 2009). Average of six independent analyses obtained from 3 independently derived cell lines is shown; statistical significance was evaluated using Student’s t‐test and P values calculated comparing hTERT derivatives to non‐hTERT control. Error bars represent ± SEM. Levels of lesions are calculated relative to the non‐hTERT control. (B) Levels of superoxide anion were estimated on NHF and its derivatives based on Mitosox fluorescence. Cells were loaded with 1 μm of Mitosox for 10 min, washed and analyzed by flow cytometry. Ten thousand cells per cell type were analyzed in three independent experiments using two independently derived cell lines. Average fluorescence values per cell line are plotted. Statistical significance was calculated using one‐way anova; *P ≤ 0.05. (C) Measurement of oxygen consumption rates were performed as described in the Experimental Procedures. Left: basal rate of respiration; right: rate of proton leak. Data are expressed as mean ± SD of N = 3 for each cell type. No statistical difference was observed between parental and NHF hTERT cells. P values between NES‐hTERT and either NHF or NHF hTERT are *P ≤ 0.05. (D) Cells were infected with NES‐hTERT pLXIN and followed for 12 weeks. At week 7, NES‐hTERT cells were split in two separate flasks, one of which was supplemented with 5 mm of NAC (for more details see Experimental Procedures). Cell number was followed for an additional 5 weeks, and the parental non‐hTERT cells were used as controls. Results are representative; similar data were obtained when NES‐hTERT was expressed in the pBabe vector (not shown). (E) Mitochondrial ultrastructure of NHF and its hTERT derivatives were analyzed by electron microscopy as described in the Experimental Procedures. Magnification = 20 500×. Arrows indicate swollen mitochondria with distended cristae. Cristae are fragmented, swollen and clumped along the outer periphery of the outer mitochondrial membrane. Lower micrograph shows a highly swollen mitochondrion in which the outer membrane has become attenuated and ruptured, imparting a vacuole‐like appearance. Electron‐lucent particles (rather than electron dense, as in normal mitochondria) are seen in the mitochondria depicted. Mitochondria in both parental and NHF hTERT are dividing (‘T’ shaped organelles) whereas no such structures are observed in the mutant.

We next measured the basal levels of ROS production in the cells using Mitosox, a dye specific for the detection of mitochondrial superoxide anion (O2). We measured Mitosox fluorescence at a single‐cell level by confocal microscopy and by fluorescence‐activated cell sorting (FACS). As the data were identical with both approaches, we depict results obtained by FACS (Fig. 5B). A negative control in which cells were exposed to 5 μm of the uncoupler FCCP revealed the specificity of the Mitosox signal (data not shown). In agreement with previous reports (Ahmed et al., 2008; Haendeler et al., 2009), lower levels of ROS were detected in cells carrying WT hTERT compared to non‐hTERT controls (Fig. 5B). Differences in oxygen consumption were ruled out as potential explanation for these data (Fig. 5C left panel). No differences were observed in the rate of proton leak between non‐hTERT and its WT derivative (Fig. 5C right panel).

Although senescent cells tend to have higher levels of ROS compared to young culture counterparts, this difference did not reach statistical significance (Fig. 5A, compared bars of extreme left and right). Consistent with higher levels of mtDNA damage in NHF NES‐hTERT, cells carrying the mutant protein also produced significantly higher basal levels of ROS (Fig. 5B). These results are in agreement with our previous report showing that cells carrying damaged mtDNA produced higher levels of ROS than cells carrying nondamaged mtDNA (Santos et al., 2003). In agreement with dysfunction, the mitochondria of these cells while consuming more oxygen had a high degree of proton leak (Fig. 5C).

The increased ROS detected may explain why cells expressing the mutant undergo premature growth arrest as higher levels of ROS could compound the defect in telomere elongation ultimately accelerating the entrance into senescence. To test this, we cultured parental and NES‐hTERT‐expressing cells under chronic antioxidant supplementation (NAC, 5 mm) and analyzed the kinetics of cell growth. As shown in Fig. 5D, NES_hTERT when cultured under NAC continued to proliferate with similar kinetics to the parental controls while, as previously observed (Fig. 2A), they stopped cycling prematurely in the absence of the antioxidant. Of note, NES‐hTERT was not able to sustain the growth beyond the PD when the non‐hTERT parental senesced even in the presence of NAC (data not shown).

Mitochondrial impairment is often accompanied by changes in organellar morphology such as swelling, loss of cristae and the appearance of megamitochondria (Kim et al., 2007). Corroborating the data mentioned earlier, analysis of mitochondrial ultrastructure by EM showed that the expression of NES‐hTERT caused marked mitochondrial swelling with loss of cristae, intramitochondrial inclusions and irregular‐shaped organelles throughout the cytoplasm (Fig. 5E and enlarged image at the bottom). No worm‐shaped mitochondria or mitochondria undergoing division (or fission) as observed in NHF and in WT controls were detected in the mutant (Fig. 5E).

Taken together, the data presented in Fig. 5 show that the mitochondria of NES‐hTERT cells are dysfunctional, supporting a role for hTERT in mitochondrial biology (Santos et al., 2004, 2006a; Ahmed et al., 2008; Haendeler et al., 2009). In addition, they suggest that the telomere elongation defect in the mutant that drives growth arrest is compounded by dysfunctional mitochondrial leading to premature entrance into senescence.

Mitochondrial dysfunction in NES‐hTERT is not a consequence of cellular senescence

It could be argued that impaired mitochondria observed in cells carrying the mutant hTERT simply reflect the senescent phenotype. We do not favor this hypothesis because the analyses mentioned earlier were performed while cells were still cycling i.e., prior to the appearance of senescence.

To directly test the involvement of senescence to the mitochondrial defects, we analyzed mtDNA damage and ROS production in GM847 fibroblasts retrovirally transduced with empty vector, WT‐ or NES‐hTERT. GM847 are immortalized cell lines that maintain telomeres through the ALT (alternative lengthening of telomeres) pathway (Stewart et al., 2002). These cells did not stop cycling or undergo senescence as a result of NES‐hTERT expression given they are p53/p16 impaired (Fig. 2D and data not shown). For mtDNA integrity and ROS production analyses, we used two independently derived cultures expressing the mutant protein. Expression of NES‐hTERT in GM847 cells also resulted in significant increases in mtDNA damage and ROS production (Fig. 6), indicating that the mitochondrial dysfunction observed in NES‐hTERT‐expressing cells does not result from the senescence phenotype. As the ALT cells maintain telomeres through a telomerase‐independent pathway, these data support the conclusion that the senescence observed in the primary cells results from the inability of NES‐hTERT to maintain telomeres.

Mitochondrial dysfunction in nuclear export signal (NES)‐hTERT cells is not dependent on short telomeres. (A) MtDNA damage analysis was performed in GM847 carrying empty vector or NES‐hTERT as in Fig. 5A; *P ≤ 0.05. (B) Mitosox fluorescence of GM847 cells carrying empty vector or NES‐hTERT as evaluated in Fig. 5B. Results represent average of two independent analyses (in duplicates) using independently derived cultures; *P ≤ 0.05.

Discussion

In this study we substituted residues in the NES of hTERT and found that the resulting mutant was nuclear but unable to immortalize cells, despite catalytic activity in vitro similar to the WT protein (Figs 1–3). These results were reproduced in two different primary strains using two different vectors, demonstrating that the effects were not related to the cellular background in which NES‐hTERT was expressed, nor related to the levels of expression of the mutant protein. We also showed that telomeres were dysfunctional, causing the activation of a classical telomere‐initiated DDR and consequently cellular senescence (Fig. 4). Mutations in the NES region also had negative impact on mitochondria as reflected by decreased mtDNA integrity, increased mitochondrial ROS generation and rate of proton leak as well as altered mitochondrial ultrastructure (Fig. 5). While likely contributing to the telomere dysfunction, the mitochondrial defects were not the cause for cellular senescence. This is based on our observations that growth arrest was not observed in an ALT cell line that also showed mitochondrial impairment (Fig. 6). Taken together, our results show that the NES region of hTERT is important not only for telomerase shuttling but also for its immortalization capacity. In addition, alterations in this region negatively impact mitochondria, corroborating a role for hTERT in mitochondrial biology.

Residues on the NES regions are required for cellular immortalization

As the only apparent defect of NES‐hTERT was its inability to translocate out of the nucleus, our data suggest that shuttling of hTERT between subcellular compartments is required for cellular immortalization.

However, it can be argued that the mutations introduced to create NES‐hTERT affected other properties of the protein, besides its ability to shuttle between nucleus and cytoplasm. For instance, it is possible that the substituted residues caused conformational changes that do not allow hTERT to interact with a protein responsible for localizing it at telomeres and/or bind telomeres (or telomeric DNA) or its associated RNA (hTR). In either case the telomere elongation function of telomerase would be compromised. This scenario, however, is unlikely given that the mutant hTERT was equally efficient as WT hTERT in binding and extending telomeres in vitro as judged by the TRAP (Fig. 3A), and binding sites between hTERT and hTR have been mapped onto the N‐terminus of hTERT (Beattie et al., 2000, 2001; Armbruster et al., 2001; Bachand & Autexier, 2001; Banik et al., 2002).

Structural studies have shown that the C‐terminus of hTERT is involved with catalytic activity and processivity but little was performed specifically in the NES region (Beattie et al., 2000, 2001; Banik et al., 2002; Hossain et al., 2002; Autexier & Lue, 2006; Middleman et al., 2006). While large amino acid substitutions (6 at a time) between amino acids 978 and 992, encompassing the NES, led to mutants unable to immortalize cells because of the complete lack of enzymatic activity, one single amino acid change at position 980 led to a slight defect in enzymatic activity as judged by the conventional assay (Banik et al., 2002, Huard et al., 2003). The latter mutant was not assayed for its ability to elongate telomeres in vivo. Based on these studies, one can conclude that mutations in the NES region are more likely associated with disruption in catalytic activity in vitro and the consequent inability of telomerase to elongate telomeres in vivo. Although our data show that problems with catalytic activity in vitro are not responsible for the effects linked to expression of NES‐hTERT, it is a formal possibility that amino acids in the NES region are directly involved with the metabolism of chromosomal telomeric substrates by telomerase in vivo besides its role in nuclear‐cytoplasmic shuttling.

The hTERT DAT mutants previously described (Armbruster et al., 2001; Banik et al., 2002) had similar phenotype as reported here for NES‐hTERT: catalytic activity in vitro but biological inactivity in vivo. However, some differences are noteworthy. For instance, while the size of telomeres were comparable between the parental strains and the NES‐hTERT or DAT mutants (Fig. 3B, Armbruster et al., 2001; Banik et al., 2002), NES‐hTERT cells consistently stopped cycling prior to the parental strains (Fig. 2A). Increased ROS generation was reported only in NES‐hTERT cells (Fig. 5). It is likely that the elevated levels of ROS compounded the telomere defect in this mutant accelerating the entrance into senescence. This conclusion is supported by findings presented in Fig. 5D. Finally, a fraction of cells expressing NES‐hTERT also presented multiple nuclei and ER stress (Fig. 1F and data not shown) which were not reported previously. Both these phenotypes can result from oxidative stress (D’Angiolella et al., 2007; Hanada et al., 2007) and could be secondary to the mitochondrial dysfunction.

Mutations in the NES region of hTERT are associated with mitochondrial dysfunction

Irrespective of the exact reason why NES‐hTERT is defective in cellular immortalization, an important finding from these studies was that mutations in the NES of hTERT had a negative impact on mitochondria. We showed that basal levels of mtDNA damage, mitochondrial ROS generation and the rate of proton leak (another marker of mitochondrial dysfunction) were all higher in cells carrying the mutant independent of the cellular background (NHF or GM847) in which it was expressed. The ultrastructure of the mitochondria of NES‐hTERT cells was also clearly altered (Fig. 5), collectively indicative of mitochondrial dysfunction.

One explanation for these data is that once translated in the cytoplasm, hTERT first translocates into the nucleus to be then exported out to mitochondria. In such case, confinement of hTERT into the nucleus leads to mitochondrial dysfunction simply by the absence of the protein in the organelle. This possibility is consistent with recent results that showed mitochondrial defects in shRNA or knockout cells for TERT (Ahmed et al., 2008; Haendeler et al., 2009). Alternatively, shuttling of hTERT between subcellular compartments may exert an additional level of regulation upon mitochondria. Such effect may be based on increasing the mitochondrial pool (in some or in all cells of the population) or it may involve cross talk and/or translocation with nuclear/cytoplasmic proteins that in turn are required for mitochondrial function.

Another potential explanation for these data is that mutations on the NES region shift the role of hTERT from telomere maintenance to gene expression regulation, possibly affecting mitochondrial‐related genes. In such case, the mutant has gained function. Interestingly, the ability of hTERT to modulate expression of gene(s) based on its RNA‐dependent RNA polymerase activity has been reported recently (Maida et al., 2009).

A gain of function mutation could also explain why NES‐hTERT‐expressing cells had dysfunctional mitochondria when compared to the parental cells. However, in the latter case one cannot exclude the possibility that NES‐hTERT exerts some degree of dominant negative activity upon endogenous hTERT in mitochondria. Although most adult somatic cells were thought to be telomerase negative, both hTERT mRNA and protein have been detected in primary strains albeit at low levels (Kilian et al., 1997; Ramakrishnan et al., 1998; Masutomi et al., 2003). Our unpublished results show that the expression of NES‐hTERT in two telomerase‐positive cancer cell lines also leads to mitochondrial dysfunction, in line with the hypothesis that NES‐hTERT has a dominant negative effect upon endogenous hTERT in the organelle (Kovalenko and Santos, in preparation).

It can be argued that the mitochondrial dysfunction was a consequence of the senescent phenotype. However, we reject this notion based on the fact that the ALT‐immortalized GM847 cells did not undergo senescence in response to NES‐hTERT expression; yet they had more dysfunctional mitochondria than controls (Fig. 6). In addition, mtDNA integrity and ROS production were analyzed prior to signs of senescence in the nonimmortalized cells (Fig. 5).

Overall, our findings show that mutations on the NES of hTERT are associated with mitochondrial dysfunction and corroborate a role for hTERT in mitochondrial biology (Santos et al., 2004, 2006a; Ahmed et al., 2008; Haendeler et al., 2009). Further, they are consistent with our previously proposed role for hTERT in mitochondrial quality control (Santos et al., 2004, 2006a).

In vivo telomere elongation function of telomerase is important for protecting nuclear DNA from ROS‐induced damage

We previously demonstrated that on average 75% of nDNA damage was localized at telomeres during replicative senescence (Herbig et al., 2004). In this study, we found that about 50% of DNA damage foci in NHF‐expressing NES‐hTERT colocalized with telomeric sequences, suggesting that TIF did not result from replication‐based telomere shortening. It is more probable that NES‐hTERT‐induced TIF and the resulting cellular senescence are a consequence of the inability of the mutant hTERT to extend telomeres. Such telomere dysfunction was likely compounded by high levels of oxidative damage resulting from dysfunctional mitochondria (Fig. 5), ultimately leading the cells to prematurely enter into senescence. Results obtained with the chronic exposure to NAC support this notion (Fig. 5D). Mitochondrially derived ROS damages nDNA as demonstrated by us in both yeast and in mammalian cells (Karthikeyan et al., 2003; Stuart et al., 2006 and this study). It is not surprising that telomeres were a target for oxidative damage given their G‐rich nature and the vulnerability of such DNA bases to ROS (Henle et al., 1999; von Zglinicki, 2002).

It is intriguing that extratelomeric DNA damage was present at such high levels; about 4 lesions per 100 000 bases of DNA are estimated to be present in the nucleus of the mutant (Fig. 4E). This degree of nDNA damage is comparable to the amount of damage incurred in SV40‐transformed fibroblasts submitted to treatment with 100 μm H2O2 (Yakes & Van Houten, 1997). The increased ROS generated by faulty mitochondria in NES‐hTERT is clearly damaging the nDNA to a higher extent than in the controls. However, maintenance of a ‘steady state’ level of lesions is likely compounded by some additional impairment in the mutant. It has been reported that hTERT modulates DNA repair (Masutomi et al., 2005). Based on our results, we can speculate that the DNA repair‐promoting properties of hTERT may require cross talk with other protein(s) that either interact with hTERT through residues in the NES region or that reside in the cytoplasm. Alternatively, hTERT modulation of DNA repair may be associated with its ability to elongate telomeres and the associated promotion of genomic stability, a concept previously proposed by others (Holt et al., 1999; Gorbunova et al., 2002; Sharma et al., 2003; Rubio et al., 2004).

Experimental procedures

Cell culture

Primary NHF telomerase negative and their respective hTERT derivatives were described and maintained as in Santos et al. (2004, 2006a). Human fibroblasts transformed with the early region of simian virus 40 (GM847) were a kind gift of Dr Robert Weinberg (Whitehead Institute, MIT); cells were maintained as described in Stewart et al., 2002. HeLa cells were obtained from ATCC. Cells were grown in Dulbecco’s modified Eagle high glucose medium (Gibco/Invitrogen, Grand Island, NY, USA) supplemented with 10% fetal bovine serum and 1% penicillin and streptomycin.

Plasmids and transfections

Retroviral pBabe and pLXIN vectors with WT hTERT were described earlier (Santos et al., 2004, 2006a). NES‐hTERT was generated by site‐directed mutagenesis of WT hTERT in EGFP, pLXIN and pBabe vectors (Santos et al., 2004, 2006a) by replacing leucine residues at position 980 and 987 for alanine (L980A/L987A hTERT). The constructs were sequenced to assure introduction of the mutations. Transient and stable transfections were performed as described previously (Santos et al., 2004, 2006a). Images were acquired using a Zeiss Axiovert 200 fluorescence microscope equipped with ApoTome. The objective lens used was the PlanApo 63×/1.4 oil differential interference microscopy, and the pinhole was set to achieve a z‐resolution of 1.0 μm.

Subcellular fractionations and Western blots

Harvested cells (5 × 107) were washed twice with PBS, centrifuged (4000 g, 5 min) and supernatants were discarded. The pellets were weighed and gently resuspended in HEPES dissociation buffer (5 mm KPO4, pH 7.5, 2 mm MgCl2, 1 mm 2‐mercaptoethanol), at 9× volume of the wet weight of the cells. Protease inhibitor cocktail (1:100 v/v) was added, and the cells were left on ice for 1 h. Once the cells were swollen (as judged with 5 μL on a slide with a 20/40 objective lens), they were broken by Dounce homogenization for 20–30 strokes until only 0–2 intact cells/microscope field remained. Mannitol–sucrose buffer (2.5×; 0.525 m mannitol, 0.175 m sucrose, 5 mm Tris–HCl, 5 mm EDTA, 5 mm MgCl2, pH 7.5) was added to a 1× concentration. To collect nuclei, the cells were centrifuged for 5 min at 1600 g (4 °C), the supernatants with remaining mitochondria were collected while the pellet was kept as the nuclear fraction. Supernatants were then centrifuged for 30 min at 12 000 g; the pellets containing mitochondria were washed three times with 1× mannitol–sucrose buffer to remove remaining nuclear DNA and proteins, and then treated with proteinase K (0.05 mg mL−1 final concentration) for 30 min on ice. Protease inhibitors were added, and samples were incubated on ice for an additional 10 min. Mitochondria were then washed three times with 1× mannitol–sucrose buffer. The mitochondrial pellets were resuspended in lysis buffer (1% NP‐40, 0.3 m NaCl, 10% glycerol, 20 mm Tris–HCl, pH 8.0, 14 mm 2‐mercaptoethanol and proteinase inhibitors) and left on ice for 10 min. The lysates were then centrifuged for 2 h at 12 000 g, and the protein was quantified using the Bradford or Lowry assays. hTERT was probed with the anti‐hTERT antibody from Epitomics (1:1000), actin with the antibody available from Millipore and ND1, a mtDNA‐encoded protein, was obtained from Santa Cruz (1:200). The latter was used to normalize the mitochondrial data presented in Fig. 1B. Purity of mitochondrial preparations was probed with antibodies against Ku80 and tubulin; enrichment of the mitochondrial fraction was evaluated based on mtHSP70 (data not shown).

Growth curves

Primary NHF and GM7532 were infected with NES‐hTERT at PD28 and 15, respectively. Cells were maintained in culture under selection with the appropriate antibiotics (puromycin or G418) for the length of the experiments. Parental cells were cultured as reference controls. Cells were seeded always at same number (50 000) in 75‐ cm2 flasks and trypsinized and counted every time they reached 100% confluence, when they were reseeded. Cells were followed for 6 weeks. For chronic antioxidant analysis, we used GM7532 parentals and the derivatives expressing NES‐hTERT given that expression of the mutant hTERT consistently led to later premature arrest in this cellular background when compared to the NHF strain (see Fig. 2A). The cultured medium supplemented with 5 mm of NAC was replaced every two days. In the case of experiments shown in Fig. 5D, cells were put under NAC after 7 weeks from the time the experiment started. The same results were obtained when NES‐hTERT was expressed in the pBabe vector (data not shown).

Cell cycle analysis

Primary and GM847 fibroblasts (and respective hTERT derivatives) were serum starved overnight and released from serum starvation by the addition of 10% FBS into the medium for 8 h. Cell cycle analysis by flow cytometry with propidium iodide (PI, Molecular Probes, Carlsbad, CA, USA) was performed as described previously (Santos et al., 2003) using a BD Biosciences FACSCalibur flow cytometer. DNA content analysis was performed by Modi Fit LT (Verity Software House, Topsham, ME, USA) software.

Analysis of senescence by β‐galactosidase activity

NHF and its derivatives were plated on 60‐ mm dishes and stained for senescence‐associated β‐galactosidase activity using the Cell staining kit (Cell Signaling) according to the manufacturer’s protocol.

Telomeric repeat amplification protocol

Hundred nanograms of total protein extracts was assayed for TRAP using TRAPeze kit (Chemicon, Temecula, CA, USA) according to manufacturer’s instructions and with some modifications (Santos et al., 2004).

Southern blots for telomeric length measurements

NHF and its hTERT derivatives were grown under identical culture conditions and harvested for DNA extraction within 8 PDs from the time they were derived. DNA was extracted with phenol:chlorophorm, and mTRF measurements performed using Southern blotting as described in Richards et al., 2008.

Immunofluorescence of DDR, p21 and p16 proteins

Cells were grown on coverslips for at least 48 h prior to immunostaining. After washing with PBS, cells were fixed for 20 min with 4% paraformaldehyde/PBS, permeabilized for 20 min with PBST (PBS containing 0.2% Triton X‐100) and blocked for 1 h with PBS/4% BSA. Cells were incubated with antibodies, diluted in blocking buffer, for 2 h at room temperature, followed by three 5‐ min washes with PBS. The secondary Alexa‐488‐ (Invitrogen) and Cy3‐ (Jackson Immunoresearch, West Grove, PA, USA) conjugated antibodies were diluted 1:1000 in blocking buffer and added to the cells for 1 h in a humidified chamber. After two 5‐ min washes with PBS, cells were mounted using DAPI containing mounting media. Primary antibodies were used at following dilutions: anti‐γH2AX (S139) (Upstate, Billerica, MA, USA), anti‐p21 (C‐19, Santa Cruz, Santa Cruz, CA, USA), anti‐p16 (JC8; Abcam, Cambridge, MA, USA), 1:1000; anti‐ATM (S1981) (Abcam), 1:200; anti‐Chk2 (T68) (Lot1; Cell Signaling), 1:500; anti‐p53(S15) (Cell Signaling, Danvers, MA, USA), 1:100. Images were acquired using a Zeiss Axiovert 200 fluorescence microscope equipped with ApoTome.

ImmunoFISH

Cells were processed and stained with anti‐γH2AX antibodies as described earlier. Following three 5‐ min washes with PBS, the cells were incubated with Alexa‐488 conjugated rabbit anti‐mouse antibodies diluted 1:1000 in PBS for 1 h. After two 5‐ min washes with PBS, the cells were incubated with 4% paraformaldehyde/PBS for 20 min, washed 2 × 5 min with PBS and dehydrated by sequentially placing them in 70%, 90% and 100% ethanol for 3 min each. Nuclear DNA was denatured for 5 min at 80 °C in hybridization buffer containing 0.5 μg mL−1 (C3TA2)3‐Cy3‐labeled peptide nucleic acid (PNA), 70% formamide, 12 mm Tris‐HCl (pH8), 5 mm KCl, 1 mm MgCl2, 0.001% Triton X‐100 and 2.5 mg mL−1 acetylated BSA. After denaturation, incubation was continued for 2 h at room temperature in a humidified chamber. Cells were washed two times for 15 min with 70% formamide/2 sodium chloride/sodium citrate (0.3 m NaCl, 30 mm Na‐ Citrate (pH 7), followed by a 10 min wash with 2× SSC and a 10 min wash with phosphate buffered saline plus Tween. To reinforce the protein signal, cells were incubated for 1 h with an Alexa‐488 conjugated goat anti‐rabbit secondary antibody. Cells were mounted as described earlier and analyzed by immunofluorescence microscopy using a Zeiss Axiovert 200 fluorescence microscope equipped with ApoTome. Images were acquired as z‐stacks spaced 0.4 μm apart using a 100× lens with 1.4 optical aperture.

DNA integrity analysis

Nuclear and mtDNA damage were estimated using QPCR as described previously (Santos et al., 2002, 2006b; Kovalenko & Santos, 2009). Basal levels of damage were analyzed using at least two independently derived cell lines. Two independent DNA extractions were performed for each cell type. The DNA was probed twice for each set of genes analyzed to assure reproducibility of the results using the same DNA. Levels of lesions are calculated relative to the amount of damage detected in the non‐hTERT control as previously described (Santos et al., 2002).

Mitosox measurements

Superoxide levels were monitored by confocal microscopy and by FACS based on MitoSox Red (Invitrogen) fluorescence. For FACS analysis, cells were loaded with 1 μm of Mitosox diluted in Hank’s buffered salt solution in tissue culture flasks and incubated at 37 °C for 10 min. Fluorescence levels were calculated based on the average results obtained for 10 000 cells per cell type. Experiments by FACS were independently repeated three times. For confocal analysis, cells were plated on glass coverslips 48 h prior to the experiment, incubated at 37 °C for 10 min with 1 μm of Mitosox diluted in HBSS buffer. After incubation, the fluorescent indicator was removed and cells were washed with warm HBSS buffer. A control using 5 μm of the mitochondrial uncoupler FCCP was included to assure specificity of the signals. Images were acquired using laser scanning confocal microscope (Radiance 2000; Bio‐Rad, Hercules, CA, USA). At least ten images were taken, and approximately 50 cells were analyzed/coverslip for each cell type. Approximately 300 cells per cell type were analyzed in three to five independent experiments.

Oxygen consumption

Oxygen consumption was monitored as described previously (Kristian et al., 2006). We performed experiments in intact cells using a closed chamber and a Clark‐type oxygen sensor (Hansatech Instruments, Norfolk, England). The same number of cells was analyzed for each cell type in triplicate experiments. The rate of respiration was calculated based on the ratio between the basal rate and the maximal rate of oxygen consumption in the presence of FCCP, an uncoupler of the mitochondria. The rate of proton leak was estimated by dividing basal O2 consumption in the presence of oligomycin (5 μg mL−1), the mitochondrial ATP synthase inhibitor alone (pseudo state 4) by the maximal rate of O2 consumption in the presence of FCCP (5 μm) and oligomycin.

Electron microscopy

NHF and its hTERT derivative were processed in sections (approximately 1 mm3), which were rapidly fixed in diluted Karnovsky’s fixative (5% Glutaraldehyde, 4% formaldehyde in 0.08 m sodium phosphate buffer). Embedded sections (0.5 μm) were cut with a glass knife and stained with Toluidine blue for orientation. Ultrathin sections were cut with a diamond knife, stained with uranyl acetate and lead citrate and viewed on a Philips Morgagni electron microscope (Philips, Amsterdam, Netherlands). Structurally damaged mitochondria were operationally defined as having loss or dissolution of ≥ 25% of cristae, alteration of size and vacuolization as judged by a pathologist. The same number of cells, from independent slides, were evaluated.

Statistical analysis

Student’s t‐test and one‐way anova were used to calculate statistical significance as described in figure legends.

Acknowledgments

We thank Ms Dana Stein for her help with FACS analysis (cell cycle and Mitosox), Ms. Deloris Sutton with help with the EM and the pathologist Dr Connie Cummings for the EM reports. We also thank all the members of the Thomas group (NJMS), in particular Dr Lawrence Gaspers, for fruitful suggestions; and Dr Michele A. Trovero (SAS Institute, Cary, NC, USA) for help with statistical analysis.

    Author contributions

    Dr Kovalenko generated data for figures 2A and B, 3, 5 and 6B, Perihan Ulema generated figure 1, Dr Kimura generated results for figure 3B, Dr Herbig generated data presented in Figs. 2C, F and 4, and Dr Bonini generated data presented in Fig. 5E. Carolina Medrano was responsible for the growth curves and NAC treatments. Dr Santos produced the data presented in figures 4E, 5A and 6A and was responsible for devising the project, analyzing the data and preparing the manuscript. Matthieu Caron contributed technically to various experiments, including performing all the cloning of the vectors used in the study. Dr Thomas contributed intellectually with various experiments throughout the manuscript.

    Funding

    This work was partially supported by the New Jersey Cancer Commission [grant numbers 808033 to JHS and 09‐1124‐CCR‐EO to UH], by the Army Research Office [grant number 56027LS to JHS] and by the Ellison Medical Foundation to UH [grant number AG‐NS‐0387‐07].

    Number of times cited: 41

    • , ZBTB48 is both a vertebrate telomere‐binding protein and a transcriptional activator, EMBO reports, 18, 6, (929-946), (2017).
    • , Transcriptional consequences of XPA disruption in human cell lines, DNA Repair, 57, (76), (2017).
    • , Excitotoxic and Radiation Stress Increase TERT Levels in the Mitochondria and Cytosol of Cerebellar Purkinje Neurons, The Cerebellum, 10.1007/s12311-015-0720-6, 15, 4, (509-517), (2015).
    • , Contributions of Telomere Biology to Human Age-Related Disease, Handbook of the Biology of Aging, 10.1016/B978-0-12-411596-5.00007-1, (205-239), (2016).
    • , Stem cell mitochondria during aging, Seminars in Cell & Developmental Biology, 52, (110), (2016).
    • , Role of XPD in cellular functions: To TFIIH and beyond, DNA Repair, 44, (136), (2016).
    • , Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell‐based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies, Journal of Biomedical Materials Research Part A, 103, 12, (3993-4023), (2015).
    • , Mitochondrial Proteins Moonlighting in the Nucleus, Trends in Biochemical Sciences, 40, 12, (728), (2015).
    • , Biomolecular bases of the senescence process and cancer. A new approach to oncological treatment linked to ageing, Ageing Research Reviews, 10.1016/j.arr.2015.03.004, 23, (125-138), (2015).
    • , Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?, Carcinogenesis, 10.1093/carcin/bgv037, 36, Suppl 1, (S203-S231), (2015).
    • , Saccharomyces cerevisiae as a model for the study of extranuclear functions of mammalian telomerase, Current Genetics, 10.1007/s00294-014-0472-8, 61, 4, (517-527), (2015).
    • , Cellular functions of the dual-targeted catalytic subunit of telomerase, telomerase reverse transcriptase — Potential role in senescence and aging, Experimental Gerontology, 10.1016/j.exger.2014.02.011, 56, (189-193), (2014).
    • , Telomerase reverse transcriptase in the regulation of gene expression, BMB Reports, 47, 1, (8), (2014).
    • , Telomere Biology in Senescence and Aging, Inflammation, Advancing Age and Nutrition, 10.1016/B978-0-12-397803-5.00007-1, (71-84), (2014).
    • , The mitochondrial genome in aging and senescence, Ageing Research Reviews, 18, (1), (2014).
    • , Implications of telomere‐independent activities of telomerase reverse transcriptase in human cancer, The FEBS Journal, 280, 14, (3205-3211), (2013).
    • , Conflict of interests: Multiple signal peptides with diverging goals, Journal of Cellular Biochemistry, 114, 3, (510-513), (2013).
    • , Mitochondrial dysfunction and nuclear‐mitochondrial shuttling of TERT are involved in cell proliferation arrest induced by G‐quadruplex ligands, FEBS Letters, 587, 11, (1656-1662), (2013).
    • , Mitochondrial Telomerase Protects Cancer Cells from Nuclear DNA Damage and Apoptosis, PLoS ONE, 8, 1, (e52989), (2013).
    • , Telomerase inhibition may contribute to accelerated mitochondrial aging induced by anti-retroviral HIV treatment, Medical Hypotheses, 81, 2, (285), (2013).
    • , The Role of Telomere Biology in Cancer, Annual Review of Pathology: Mechanisms of Disease, 8, 1, (49), (2013).
    • , The neuroprotective role and mechanisms of TERT in neurons with oxygen–glucose deprivation, Neuroscience, 10.1016/j.neuroscience.2013.08.015, 252, (346-358), (2013).
    • , Telomeres—structure, function, and regulation, Experimental Cell Research, 319, 2, (133), (2013).
    • , Human telomerase acts as a hTR-independent reverse transcriptase in mitochondria, Nucleic Acids Research, 40, 2, (712), (2012).
    • , Axis of ageing: telomeres, p53 and mitochondria, Nature Reviews Molecular Cell Biology, 13, 6, (397), (2012).
    • , Human telomerase represses ROS-dependent cellular responses to Tumor Necrosis Factor-α without affecting NF-κB activation, Cellular Signalling, 24, 3, (708), (2012).
    • , Telomerase Biogenesis: RNA Processing, Trafficking, and Protein Interactions, Telomerases, (79-103), (2012).
    • , Abnormalities in Growth Control, Telomerase Activity, Apoptosis, and Angiogenesis Linked to Mitochondrial Dysfunction, Cancer as a Metabolic Disease, (207-213), (2012).
    • , In Vitro and Ex Vivo Inhibition of Human Telomerase by Anti-HIV Nucleoside Reverse Transcriptase Inhibitors (NRTIs) but Not by Non-NRTIs, PLoS ONE, 7, 11, (e47505), (2012).
    • , Increased telomerase activity and vitamin D supplementation in overweight African Americans, International Journal of Obesity, 36, 6, (805), (2012).
    • , Telomere dysfunction induces metabolic and mitochondrial compromise, Nature, 475, 7355, (254), (2011).
    • , Telomerase reverse transcriptase: A novel neuroprotective mechanism involved in neonatal hypoxic-ischemic brain injury, International Journal of Developmental Neuroscience, 10.1016/j.ijdevneu.2011.07.010, 29, 8, (867-872), (2011).
    • , Telomere length in cardiovascular disease: new challenges in measuring this marker of cardiovascular aging, Future Cardiology, 7, 6, (789), (2011).
    • , Non-telomeric activities of telomerase, Molecular BioSystems, 10.1039/c0mb00268b, 7, 4, (1013), (2011).
    • , PinX1 the tail on the chromosome, Journal of Clinical Investigation, 121, 4, (1242), (2011).
    • , Is telomerase a potential target for vascular rejuvenation?, Atherosclerosis, 216, 1, (19), (2011).
    • , Transcriptional regulation of the human telomerase reverse transcriptase, Transcription, 10.4161/trns.1.1.12062, 1, 1, (27-31), (2014).
    • , The Emerging Role of Telomerase Reverse Transcriptase in Mitochondrial DNA Metabolism, Journal of Nucleic Acids, 10.4061/2010/390791, 2010, (1-7), (2010).
    • , Expression of NES-hTERT in Cancer Cells Delays Cell Cycle Progression and Increases Sensitivity to Genotoxic Stress, PLoS ONE, 10.1371/journal.pone.0010812, 5, 5, (e10812), (2010).
    • , Differential Protein Distribution between the Nucleus and Mitochondria: Implications in Aging, Frontiers in Genetics, 10.3389/fgene.2016.00162, 7, (2016).
    • , Current Insights to Regulation and Role of Telomerase in Human Diseases, Antioxidants, 10.3390/antiox6010017, 6, 1, (17), (2017).